Shares of Horizon Therapeutics Public Ltd. Co. (HZNP) are gaining over 15% on Wednesday morning after the company's second-quarter results trumped Wall Street view, driven by "tremendous" response for its drug Tepezza, a treatment for Thyroid Eye Disease. The company also lifted its full-year revenue outlook.
from RTT - Earnings https://ift.tt/2BZUhY2
via IFTTT
No comments:
Post a Comment